Cancer Incidence and Mortality among Black Individuals, Monroe County, 2016-2020
Source: New York State Cancer Registry
Site of Cancer | Incidence | Mortality | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
All Invasive Malignant Tumors | 581.6 | 523.9 | 504.4-543.9 | 297.2 | 625.7 | 592.6-660.1 | 284.4 | 451.5 | 427.8-476.1 | 196.0 | 187.6 | 175.6-200.2 | 98.0 | 226.8 | 206.0-249.0 | 98.0 | 161.1 | 146.8-176.3 |
Oral cavity and pharynx | 9.6 | 8.2 | 6.0-10.9 | 6.0 | 11.8 | 7.8-17.2 | 3.6 | 5.5 | 3.2-8.7 | 2.2 | 2.0 | 1.0-3.7 | 1.6 | 3.4 | 1.4-7.0 | 0.6 | 1.0 | 0.2-2.9 |
Esophagus | 4.0 | 3.9 | 2.4-6.1 | 2.8 | 6.9 | 3.7-11.6 | 1.2 | 1.9 | 0.7-4.2 | 3.8 | 3.8 | 2.3-6.1 | 1.8 | 5.0 | 2.2-9.4 | 2.0 | 3.2 | 1.5-5.9 |
Stomach | 13.4 | 12.8 | 9.8-16.4 | 7.6 | 15.9 | 11.0-22.1 | 5.8 | 10.3 | 6.8-14.8 | 5.6 | 5.5 | 3.6-8.0 | 4.2 | 9.1 | 5.5-14.1 | 1.4 | 2.7 | 1.1-5.5 |
Colorectal | 49.2 | 44.4 | 38.9-50.5 | 25.4 | 54.6 | 45.1-65.4 | 23.8 | 37.3 | 30.8-44.7 | 18.2 | 16.9 | 13.5-20.8 | 10.2 | 22.2 | 16.3-29.5 | 8.0 | 13.2 | 9.3-18.0 |
Colon excluding rectum | 34.0 | 31.1 | 26.5-36.3 | 16.8 | 36.7 | 29.0-45.8 | 17.2 | 27.3 | 21.7-33.8 | 14.4 | 13.6 | 10.6-17.2 | 7.8 | 17.4 | 12.1-24.0 | 6.6 | 11.0 | 7.5-15.5 |
Rectum & rectosigmoid | 15.2 | 13.3 | 10.4-16.7 | 8.6 | 17.9 | 12.8-24.3 | 6.6 | 10.0 | 6.8-14.2 | 3.8 | 3.3 | 1.9-5.2 | 2.4 | 4.8 | 2.4-8.7 | 1.4 | 2.2 | 0.9-4.5 |
Liver / intrahepatic bile duct | 13.6 | 11.1 | 8.5-14.2 | 10.0 | 18.6 | 13.6-24.9 | 3.6 | 5.4 | 3.1-8.6 | 11.0 | 9.7 | 7.2-12.7 | 7.8 | 15.8 | 11.0-21.9 | 3.2 | 5.1 | 2.9-8.4 |
Pancreas | 20.4 | 19.8 | 16.1-24.2 | 9.4 | 21.1 | 15.2-28.5 | 11.0 | 18.8 | 14.0-24.5 | 16.0 | 15.3 | 12.0-19.2 | 7.4 | 16.0 | 11.0-22.3 | 8.6 | 14.6 | 10.5-19.8 |
Larynx | 4.8 | 4.3 | 2.7-6.4 | 3.8 | 8.1 | 4.7-12.9 | 1.0 | 1.6 | 0.5-3.7 | 2.0 | 1.8 | 0.8-3.3 | 1.6 | 3.4 | 1.4-6.8 | 0.4 | 0.6 | 0.1-2.2 |
Lung and bronchus | 83.4 | 74.6 | 67.4-82.4 | 44.8 | 97.6 | 84.6-112.1 | 38.6 | 58.9 | 50.7-68.0 | 46.0 | 42.7 | 37.1-48.7 | 24.4 | 55.3 | 45.4-66.5 | 21.6 | 33.9 | 27.7-41.1 |
Melanoma of the skin | 0.8 | 0.8 | 0.2-2.1 | 0.4 | 1.0 | 0.1-3.5 | 0.4 | 0.7 | 0.1-2.5 | 0.2 | 0.2 | 0.0-1.0 | 0.0 | 0.0 | 0.0-1.6 | 0.2 | 0.3 | 0.0-1.7 |
Female breast | 91.6 | 146.6 | 133.2-160.9 | 15.4 | 26.2 | 20.6-32.9 | ||||||||||||
Cervix uteri | 5.6 | 8.7 | 5.7-12.6 | 2.4 | 3.9 | 2.0-6.8 | ||||||||||||
Corpus uterus and NOS | 20.4 | 30.7 | 24.9-37.4 | 7.2 | 10.2 | 7.1-14.3 | ||||||||||||
Ovary | 4.8 | 7.7 | 4.9-11.5 | 3.2 | 5.6 | 3.2-9.1 | ||||||||||||
Prostate | 103.4 | 210.3 | 191.7-230.0 | 11.8 | 33.9 | 25.4-44.0 | ||||||||||||
Testis | 0.4 | 0.8 | 0.1-2.9 | 0.0 | 0.0 | 0.0-1.6 | ||||||||||||
Urinary bladder (incl. in situ) | 13.8 | 13.4 | 10.3-17.1 | 8.4 | 19.4 | 13.6-26.6 | 5.4 | 9.2 | 6.0-13.5 | 1.8 | 1.9 | 0.9-3.7 | 1.2 | 3.0 | 1.0-6.6 | 0.6 | 1.2 | 0.2-3.3 |
Kidney and renal pelvis | 33.2 | 29.4 | 25.0-34.4 | 19.6 | 39.2 | 31.5-48.1 | 13.6 | 21.9 | 16.9-27.9 | 2.8 | 2.8 | 1.5-4.7 | 2.0 | 4.7 | 2.2-8.8 | 0.8 | 1.4 | 0.4-3.6 |
Brain and other central nervous system | 4.2 | 3.4 | 2.1-5.3 | 2.2 | 4.0 | 1.9-7.5 | 2.0 | 3.0 | 1.4-5.5 | 2.6 | 2.2 | 1.1-3.8 | 1.6 | 3.3 | 1.4-6.6 | 1.0 | 1.4 | 0.5-3.3 |
Thyroid | 12.0 | 10.6 | 8.1-13.8 | 3.2 | 7.3 | 4.0-12.0 | 8.8 | 13.4 | 9.7-18.1 | 0.8 | 0.8 | 0.2-2.1 | 0.4 | 1.1 | 0.1-3.7 | 0.4 | 0.7 | 0.1-2.4 |
Hodgkin lymphoma | 3.6 | 3.0 | 1.7-4.7 | 2.4 | 4.5 | 2.3-8.1 | 1.2 | 1.7 | 0.6-3.8 | 0.2 | 0.1 | 0.0-0.9 | 0.2 | 0.3 | 0.0-2.1 | 0.0 | 0.0 | 0.0-1.2 |
Non-Hodgkin lymphomas | 18.6 | 17.1 | 13.7-21.0 | 11.8 | 26.0 | 19.4-34.0 | 6.8 | 10.9 | 7.5-15.3 | 4.0 | 4.0 | 2.4-6.2 | 2.2 | 5.7 | 2.7-10.4 | 1.8 | 2.9 | 1.3-5.6 |
Myeloma | 14.2 | 13.4 | 10.4-17.0 | 7.8 | 18.3 | 12.7-25.3 | 6.4 | 10.2 | 6.9-14.5 | 4.8 | 5.1 | 3.2-7.6 | 2.8 | 7.4 | 3.9-12.4 | 2.0 | 3.5 | 1.7-6.5 |
Leukemias | 11.0 | 10.8 | 8.1-14.2 | 6.2 | 13.4 | 8.9-19.4 | 4.8 | 8.6 | 5.5-12.9 | 7.8 | 8.0 | 5.6-10.9 | 4.4 | 10.2 | 6.2-15.6 | 3.4 | 6.3 | 3.6-10.0 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.